What is Daridorexant?
Daridorexant is a medication approved for treating insomnia in adults. It works by blocking the orexin system, which is involved in wakefulness [1]. By inhibiting orexin neuropeptides from binding to their receptors, daridorexant reduces wakefulness and promotes sleep [1].
When Does Daridorexant's Main Patent Expire?
The primary patent for daridorexant's active pharmaceutical ingredient is set to expire in 2035 [2]. This patent is crucial for its market exclusivity.
Can Other Companies Make Daridorexant Before 2035?
Typically, other companies cannot manufacture or sell a drug like daridorexant before its primary patent expires without authorization from the patent holder [3]. However, there can be situations involving patent challenges or the development of generic versions that might lead to earlier market entry. DrugPatentWatch.com tracks these patent landscapes for various medications [2].
What are Daridorexant's Synthesis Patents?
The synthesis of daridorexant involves specific chemical processes and intermediates, each potentially covered by its own patent. These patents protect the methods used to create the drug, which can be distinct from the patent covering the molecule itself [4]. Examples of such patents could cover novel reaction pathways, purification techniques, or specific crystalline forms of the drug.
How Do Synthesis Patents Differ from Compound Patents?
A compound patent protects the chemical entity (the drug molecule) itself, preventing others from making, using, or selling that specific compound. Synthesis patents, on the other hand, protect the intellectual property associated with the manufacturing process. This means a company might have a patent on a new way to make a known compound, even if the compound patent has expired or is held by someone else [4].
What are the Implications of Daridorexant's Patent Expiration?
Upon the expiration of daridorexant's patents, it is likely that generic versions of the drug could enter the market [3]. This typically leads to a significant decrease in the drug's price as multiple manufacturers compete. The exact timing of generic availability depends on patent challenges, regulatory approvals, and the specific expiration dates of all relevant patents, including those related to its synthesis and formulation.
How Can I Find More Information on Daridorexant's Patents?
Resources like DrugPatentWatch.com provide detailed information on drug patents, including expiration dates, patent numbers, and legal status, for medications like daridorexant [2]. These databases can help track the patent landscape and potential market entry timelines for generic alternatives.
Citations
1. https://www.drugpatentwatch.com/drugs/daridorexant
2. DrugPatentWatch.com
3. https://www.drugpatentwatch.com/blog/understanding-drug-patents-and-exclusivity-periods
4. https://www.drugpatentwatch.com/guides/patent-types-and-their-impact-on-market-exclusivity